Edition:
United Kingdom

People: Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

717.96GBp
12:40pm BST
Change (% chg)

-4.04 (-0.56%)
Prev Close
722.00
Open
730.00
Day's High
730.00
Day's Low
716.00
Volume
9,813
Avg. Vol
73,838
52-wk High
1,029.40
52-wk Low
575.32

Heath, Andrew 

Dr. Andrew J. Heath, M.D., Ph.D., serves as Non-Executive Deputy Chairman of the Board, Senior Independent Director of Oxford BioMedica PLC. Dr Heath is a biopharmaceutical executive with in-depth knowledge of US and UK capital markets and international experience in marketing and sales, R & D and business development. He was Chief Executive Officer of Protherics plc from 1997 to 2008, taking the Company from 30 to 350 staff and managing its eventual acquisition by BTG for £220 million. Prior to this, Dr Heath held senior positions at Astra AB and Astra USA, including Vice President Marketing & Sales, and at Glaxo Sweden as Associate Medical Director.

Basic Compensation

Total Annual Compensation, GBP 46,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 46,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --